Invention Grant
- Patent Title: Aureobasidium derivatives and methods of synthesis
-
Application No.: US16323601Application Date: 2017-08-08
-
Publication No.: US11066447B2Publication Date: 2021-07-20
- Inventor: Peter Wuts , Ake P. Elhammer
- Applicant: AureoGen Biosciences, Inc.
- Applicant Address: US MI Kalamazoo
- Assignee: AureoGen Biosciences, Inc.
- Current Assignee: AureoGen Biosciences, Inc.
- Current Assignee Address: US MI Kalamazoo
- Agency: Honigman LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- International Application: PCT/US2017/045851 WO 20170808
- International Announcement: WO2018/031521 WO 20180215
- Main IPC: C07K11/02
- IPC: C07K11/02 ; A61K38/00 ; A61P31/10 ; A01N43/72 ; A01N43/90
Abstract:
In general, the invention relates to AbA derivatives that are useful for treating infection. These novel compounds are shown to be effective in treating various fungal infections. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various fungal infections.
Public/Granted literature
- US20190292225A1 AUREOBASIDIUM DERIVATIVES AND METHODS OF SYNTHESIS Public/Granted day:2019-09-26
Information query
